Short Courses | Day 1 | Day 2 | Day 3 | Download Brochure

• Potential targets – innumerable

• Promising treatments – attainable

• Plenty of Challenges – surmountable

The concept of gene therapy has long appealed to biomedical researchers and clinicians because of the promise to treat certain diseases at their origin.  However, negative results and publicity have necessitated a low profile for gene therapy research.  Researchers are, in fact, quietly making progress and are confident that gene transfer will be elevated from its current experimental status to a therapeutic modality.  Scientifically, major challenges remain: targeting the right gene to the right location in the right cells and expressing it at the right time, all while minimizing any adverse reactions.  In addition, collaborations between academia and industry are of critical importance for the future of gene therapy. Substantial knowledge as well as regulatory and financial resources is needed to move gene therapy from small-scale endeavors to clinical use.  CHI’s Inaugural Targeting Gene Therapy & Gene Transfer: Translation from Basic Research to Clinical Results assembles prominent scientific researchers, clinicians, businessmen, and regulators who represent wide areas of expertise to provide the forum for discussion for expanding the potential and promise of gene therapies.

Short Courses | Day 1 | Day 2 | Day 3 | Download Brochure